前列腺MRI深度学习算法与不同经验放射科医生在病灶检测及PI-RADS分类中的性能比较
该回顾性研究纳入121例接受活检前MRI及前列腺穿刺的患者,比较深度学习算法(DLA)、临床报告及不同经验放射科医生(住院医师、低年资、专家)基于双参数MRI检测病灶并按PI-RADS分类的性能,以病理为参考标准。DLA诊断临床显著癌(Gleason≥7)的AUROC为0.828,高于住院医师(0.706),低于专家(0.914),与临床报告及其他读者相似;在PI-RADS≥4阈值下,DLA敏感度76.7%,特异度85.9%,特异度高于部分读者及临床报告。
要点
- DLA诊断临床显著癌的AUROC为0.828,性能介于住院医师与专家之间,与临床报告相似。
- PI-RADS≥4时DLA敏感度76.7%、特异度85.9%,特异度高于部分低年资读者。
- DLA可用于辅助低年资医生提高特异性,但尚不能替代专家判读。
核心结论
- DLA在前列腺MRI病灶检测及PI-RADS分类中表现出中等诊断性能,水平介于住院医师与专家之间,与临床实践中的临床报告相似。
研究设计与样本
- 回顾性研究,纳入121例接受活检前MRI及前列腺穿刺的患者,以病理报告为参考标准。
- 由超过5名放射科医生(读者1、2为住院医师;读者3、4为低年资放射科医生;读者5为专家)独立审阅双参数MRI(bpMRI),DLA结果基于bpMRI获得。
- 采用AUROC分析DLA、临床报告及放射科医生PI-RADS分类的诊断性能,并以PI-RADS≥3或≥4为阈值进行二分法分析,用McNemar检验比较敏感度和特异度。
诊断标准与关键数值
- 临床显著癌定义为Gleason评分≥7,43例(35.5%)确认存在临床显著癌。
- DLA诊断临床显著癌的AUROC为0.828,显著高于读者1(0.706,p=0.011),显著低于读者5(0.914,p=0.013),与临床报告及其他读者相似(p=0.060-0.661)。
- PI-RADS cutoff值≥4时,DLA敏感度为76.7%,与所有读者及临床报告相当;DLA特异度为85.9%,显著高于临床报告及读者2-3,与其他读者相当。
临床应用与阅片要点
- DLA可作为辅助工具用于前列腺MRI病灶检测和PI-RADS分类,尤其可能帮助低年资医生提高特异度。
- DLA性能与临床报告相似,但低于专家,提示在关键病例中仍需专家复核。
局限性
- 回顾性单中心研究,样本量121例,结论需外部验证。
- 读者数量及经验分布有限,可能影响性能比较的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the performance of lesion detection and Prostate Imaging-Reporting and Data System (PI-RADS) classification between a deep learning-based algorithm (DLA), clinical reports and radiologists with different levels of experience in prostate MRI.
METHODS: This retrospective study included 121 patients who underwent prebiopsy MRI and prostate biopsy. More than five radiologists (Reader groups 1, 2: residents; Readers 3, 4: less-experienced radiologists; Reader 5: expert) independently reviewed biparametric MRI (bpMRI). The DLA results were obtained using bpMRI. The reference standard was based on pathologic reports. The diagnostic performance of the PI-RADS classification of DLA, clinical reports, and radiologists was analyzed using AUROC. Dichotomous analysis (PI-RADS cutoff value ≥ 3 or 4) was performed, and the sensitivities and specificities were compared using McNemar's test.
RESULTS: Clinically significant cancer [CSC, Gleason score ≥ 7] was confirmed in 43 patients (35.5%). The AUROC of the DLA (0.828) for diagnosing CSC was significantly higher than that of Reader 1 (AUROC, 0.706; p = 0.011), significantly lower than that of Reader 5 (AUROC, 0.914; p = 0.013), and similar to clinical reports and other readers (p = 0.060-0.661). The sensitivity of DLA (76.7%) was comparable to those of all readers and the clinical reports at a PI-RADS cutoff value ≥ 4. The specificity of the DLA (85.9%) was significantly higher than those of clinical reports and Readers 2-3 and comparable to all others at a PI-RADS cutoff value ≥ 4.
CONCLUSIONS: The DLA showed moderate diagnostic performance at a level between those of residents and an expert in detecting and classifying according to PI-RADS. The performance of DLA was similar to that of clinical reports from various radiologists in clinical practice.
引用
- Youn SY, Choi MH, Kim DH, et al. Detection and PI-RADS classification of focal lesions in prostate MRI: Performance comparison between a deep learning-based algorithm (DLA) and radiologists with various levels of experience. Eur J Radiol. 2021. PMID: 34388625. doi:10.1016/j.ejrad.2021.109894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。